Structure-based design of a B cell antigen from B. pseudomallei.
暂无分享,去创建一个
Alessandro Gori | Oscar Conchillo-Solé | Xavier Daura | Giorgio Colombo | Ganjana Lertmemongkolchai | Claudio Peri | Mario Ferrer-Navarro | X. Daura | G. Colombo | C. Peri | G. Quilici | G. Musco | A. Gori | M. Ferrer-Navarro | Ò. Conchillo-Solé | Rachael J. Thomas | Arnone Nithichanon | G. Lertmemongkolchai | R. Titball | Davide Gaudesi | Arnone Nithichanon | Richard Titball | Giovanna Musco | Giacomo Quilici | Davide Gaudesi | Rachael Thomas | R. Thomas
[1] Matthew A. Kayala,et al. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens , 2009, Proceedings of the National Academy of Sciences.
[2] M. Bolognesi,et al. Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections , 2011, Proceedings of the National Academy of Sciences.
[3] N. Ketheesan,et al. Evidence of Burkholderia pseudomallei-Specific Immunity in Patient Sera Persistently Nonreactive by the Indirect Hemagglutination Assay , 2011, Clinical and Vaccine Immunology.
[4] A. Cheng,et al. The global distribution of Burkholderia pseudomallei and melioidosis: an update. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[5] Richard W Titball,et al. Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis , 2011, BMC Microbiology.
[6] Liisa Holm,et al. Dali server: conservation mapping in 3D , 2010, Nucleic Acids Res..
[7] Gert Vriend,et al. CING: an integrated residue-based structure validation program suite , 2012, Journal of Biomolecular NMR.
[8] R. Rappuoli,et al. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. , 2012, Vaccine.
[9] G. Colombo,et al. Peptides for immunological purposes: design, strategies and applications , 2013, Amino Acids.
[10] Y. Suputtamongkol,et al. Recent developments in laboratory diagnosis of melioidosis. , 2000, Acta tropica.
[11] Michael Nilges,et al. ARIA2: Automated NOE assignment and data integration in NMR structure calculation , 2007, Bioinform..
[12] P. Aldhous. Tropical medicine: Melioidosis? Never heard of it... , 2005, Nature.
[13] T. Straatsma,et al. THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .
[14] A. Bax,et al. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts , 2009, Journal of biomolecular NMR.
[15] X. Daura,et al. Structural and Biochemical Characterization of NarE, an Iron-containing ADP-ribosyltransferase from Neisseria meningitidis* , 2011, The Journal of Biological Chemistry.
[16] I. A. Grishina,et al. The role of agglutination in bacterial infection , 2006, Bulletin of Experimental Biology and Medicine.
[17] Wilfred F van Gunsteren,et al. Biomolecular modeling: Goals, problems, perspectives. , 2006, Angewandte Chemie.
[18] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[19] Nicholas J. White,et al. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei , 2006, Nature Reviews Microbiology.
[20] R. Rappuoli,et al. Structural vaccinology starts to deliver , 2012, Nature Reviews Microbiology.
[21] H. Berendsen,et al. Essential dynamics of proteins , 1993, Proteins.
[22] B. Wren,et al. Characterization of the Burkholderia pseudomallei K96243 Capsular Polysaccharide I Coding Region , 2012, Infection and Immunity.
[23] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[24] Andrea J. Dowling,et al. Novel gain of function approaches for vaccine candidate identification in Burkholderia pseudomallei , 2013, Front. Cell. Inf. Microbio..
[25] G. Quilici,et al. 1H, 13C, 15N backbone and side chain NMR resonance assignments of BPSL1050 from Burkholderia pseudomallei , 2014, Biomolecular NMR assignments.
[26] Rino Rappuoli,et al. From empiricism to rational design: a personal perspective of the evolution of vaccine development , 2014, Nature Reviews Immunology.
[27] T. Kodadek. Chemical tools to monitor and manipulate the adaptive immune system. , 2014, Chemistry & biology.
[28] Y. Gan. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? , 2005, The Journal of infectious diseases.
[29] Xavier Daura,et al. Exploiting Antigenic Diversity for Vaccine Design , 2010, The Journal of Biological Chemistry.
[30] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[31] N. Day,et al. Melioidosis Vaccines: A Systematic Review and Appraisal of the Potential to Exploit Biodefense Vaccines for Public Health Purposes , 2012, PLoS neglected tropical diseases.
[32] Martin Zacharias,et al. Prediction of protein-protein interaction sites using electrostatic desolvation profiles. , 2010, Biophysical journal.
[33] R. Titball,et al. Progress toward development of vaccines against melioidosis: A review. , 2010, Clinical therapeutics.
[34] Alessandro Gori,et al. A structure-based strategy for epitope discovery in Burkholderia pseudomallei OppA antigen. , 2013, Structure.
[35] S. Puthucheary,et al. Multiple-antigen ELISA for melioidosis - a novel approach to the improved serodiagnosis of melioidosis , 2013, BMC Infectious Diseases.
[36] Alessandro Gori,et al. Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology. , 2013, Chemistry & biology.
[37] J. Goldberg,et al. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei , 2008, Expert review of vaccines.
[38] Giorgio Colombo,et al. Modeling Signal Propagation Mechanisms and Ligand-Based Conformational Dynamics of the Hsp90 Molecular Chaperone Full-Length Dimer , 2009, PLoS Comput. Biol..
[39] Wayne Boucher,et al. The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.
[40] Rino Rappuoli,et al. Structure-based antigen design: a strategy for next generation vaccines , 2008, Trends in Biotechnology.
[41] A. Cheng,et al. Melioidosis: Epidemiology, Pathophysiology, and Management , 2005, Clinical Microbiology Reviews.
[42] B. Drasar,et al. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. , 1998, Microbios.
[43] S. Sirisinha. Diagnostic value of serological tests for melioidosis in an endemic area. , 1991, Asian Pacific journal of allergy and immunology.
[44] C. G. Bull. THE AGGLUTINATION OF BACTERIA IN VIVO , 1915, The Journal of experimental medicine.
[45] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[46] A. Pastore,et al. Solution structure of the bacterial frataxin ortholog, CyaY: mapping the iron binding sites. , 2004, Structure.